In a follow-up study, by directly modulating IFN-I signaling via the prophylactic administration of a mutated IFNalpha-2 (IFN modulator, IFNmod), we have observed a highly significant and consistent reduction in SARS-CoV-2 viral loads in the lower and upper respiratory tract.
1
—
—